agilon health (AGL) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $88.45, +1.20% vs the prior close of $87.40.
- Volume 137.40K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AGL rises 1.2% to $88.45, 4 up days in a row. Closed at $88.45, +1.20% vs the prior close of $87.40. Day range $85.57–$88.64, opened at $86.59.
AGL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — AGL rises 1.2% to $88.45, 4 up days in a row
- Closed at $88.45, +1.20% vs the prior close of $87.40. Day range $85.57–$88.64, opened at $86.59.
- Volume was 137.40K shares, 0.5x its 50-day average of 267.28K — lighter than usual.
- Price is -0.2% vs its 50-day average ($88.60) and +44.4% vs its 200-day average ($61.24).
- 52-week range $7.48–$133.04; today's close sits at 64% of that range, 33.5% below the 52-week high.
- That makes 4 straight gains.
Oct 14, 2026 — AGL rises 1.7% to $87.40, 3 up days in a row
- Closed at $87.40, +1.75% vs the prior close of $85.90. Day range $84.08–$87.40, opened at $84.08.
- Volume was 145.30K shares, 0.5x its 50-day average of 273.04K — lighter than usual.
- Price is -1.8% vs its 50-day average ($88.99) and +43.5% vs its 200-day average ($60.89).
- 52-week range $7.48–$133.04; today's close sits at 64% of that range, 34.3% below the 52-week high.
- That makes 3 straight gains.
Oct 13, 2026 — AGL rises 0.5% to $85.90
- Closed at $85.90, +0.48% vs the prior close of $85.49. Day range $83.42–$87.09, opened at $86.36.
- Volume was 153.30K shares, 0.6x its 50-day average of 278.49K — lighter than usual.
- Price is -3.6% vs its 50-day average ($89.14) and +41.9% vs its 200-day average ($60.54).
- 52-week range $7.48–$133.04; today's close sits at 62% of that range, 35.4% below the 52-week high.
Oct 12, 2026 — AGL jumps 3.8% to $85.49
- Closed at $85.49, +3.76% vs the prior close of $82.39. Day range $81.16–$86.50, opened at $81.74.
- Volume was 158.70K shares, 0.6x its 50-day average of 278.80K — lighter than usual.
- Price is -4.3% vs its 50-day average ($89.30) and +42.0% vs its 200-day average ($60.20).
- 52-week range $7.48–$133.04; today's close sits at 62% of that range, 35.7% below the 52-week high.
Oct 9, 2026 — AGL dips 2.8% to $82.39
- Closed at $82.39, -2.75% vs the prior close of $84.72. Day range $82.36–$88.12, opened at $85.68.
- Volume was 171.90K shares, 0.6x its 50-day average of 278.76K.
- Price is -7.9% vs its 50-day average ($89.42) and +37.6% vs its 200-day average ($59.86).
- 52-week range $7.48–$133.04; today's close sits at 60% of that range, 38.1% below the 52-week high.
Oct 8, 2026 — AGL dips 1.1% to $84.72
- Closed at $84.72, -1.14% vs the prior close of $85.70. Day range $82.06–$84.83, opened at $84.07.
- Volume was 222.40K shares, 0.8x its 50-day average of 281.04K.
- Price is -5.6% vs its 50-day average ($89.71) and +42.3% vs its 200-day average ($59.54).
- 52-week range $7.48–$133.04; today's close sits at 62% of that range, 36.3% below the 52-week high.
Oct 7, 2026 — AGL rises 2.8% to $85.70
- Closed at $85.70, +2.76% vs the prior close of $83.40. Day range $81.99–$87.84, opened at $81.99.
- Volume was 355.70K shares, 1.3x its 50-day average of 282.05K.
- Price is -4.6% vs its 50-day average ($89.87) and +44.8% vs its 200-day average ($59.20).
- 52-week range $7.48–$133.04; today's close sits at 62% of that range, 35.6% below the 52-week high.
Oct 6, 2026 — AGL dips 1.0% to $83.40
- Closed at $83.40, -1.04% vs the prior close of $84.28. Day range $82.99–$86.26, opened at $85.14.
- Volume was 168.50K shares, 0.6x its 50-day average of 286.38K — lighter than usual.
- Price is -7.5% vs its 50-day average ($90.14) and +41.7% vs its 200-day average ($58.86).
- 52-week range $7.48–$133.04; today's close sits at 60% of that range, 37.3% below the 52-week high.
Oct 5, 2026 — AGL ends flat (+0.2%) to $84.28, 4 up days in a row
- Closed at $84.28, +0.17% vs the prior close of $84.14. Day range $82.60–$85.82, opened at $83.28.
- Volume was 188.10K shares, 0.7x its 50-day average of 287.57K.
- Price is -6.8% vs its 50-day average ($90.44) and +44.0% vs its 200-day average ($58.53).
- 52-week range $7.48–$133.04; today's close sits at 61% of that range, 36.7% below the 52-week high.
- That makes 4 straight gains.
Oct 2, 2026 — AGL rises 2.3% to $84.14, 3 up days in a row
- Closed at $84.14, +2.26% vs the prior close of $82.28. Day range $82.03–$86.61, opened at $83.80.
- Volume was 205.10K shares, 0.7x its 50-day average of 293.91K.
- Price is -7.2% vs its 50-day average ($90.71) and +44.6% vs its 200-day average ($58.19).
- 52-week range $7.48–$133.04; today's close sits at 61% of that range, 36.8% below the 52-week high.
- That makes 3 straight gains.
AGL latest news & SEC filings
Every SEC filing by or about AGL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.49B (prior year $1.39B) (+7.2% vs Jun 30, 2025)
- Net income: $17.96M (prior year -$104.37M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $1.04 (prior year -$6.31) (swung to profit vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 22, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade AGL
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 25, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.39% (largest 10.3%).
- Liquidity: about 235.28K shares (≈$20.81M) trade per day on average.
- 52-week position: $88.45 vs a range of $7.48–$133.04 (64% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Mar 31, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 5 open-market buys, 0 sales; latest: Girish Venkatachaliah bought 18,448 shares on Mar 9, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 22, 2026.
- Share count: 16.79M shares outstanding (Jul 30, 2026), -95.9% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Services-Misc Health & Allied Services, NEC.
AGL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 86.59 | 88.64 | 85.57 | 88.45 | 137.40K |
| Oct 14, 2026 | 84.08 | 87.40 | 84.08 | 87.40 | 145.30K |
| Oct 13, 2026 | 86.36 | 87.09 | 83.42 | 85.90 | 153.30K |
| Oct 12, 2026 | 81.74 | 86.50 | 81.16 | 85.49 | 158.70K |
| Oct 9, 2026 | 85.68 | 88.12 | 82.36 | 82.39 | 171.90K |
| Oct 8, 2026 | 84.07 | 84.83 | 82.06 | 84.72 | 222.40K |
| Oct 7, 2026 | 81.99 | 87.84 | 81.99 | 85.70 | 355.70K |
| Oct 6, 2026 | 85.14 | 86.26 | 82.99 | 83.40 | 168.50K |
| Oct 5, 2026 | 83.28 | 85.82 | 82.60 | 84.28 | 188.10K |
| Oct 2, 2026 | 83.80 | 86.61 | 82.03 | 84.14 | 205.10K |
| Oct 1, 2026 | 79.35 | 83.94 | 77.71 | 82.28 | 262.30K |
| Sep 30, 2026 | 79.16 | 79.85 | 76.52 | 79.59 | 327.30K |
| Sep 29, 2026 | 79.66 | 79.75 | 76.93 | 78.15 | 181.10K |
| Sep 28, 2026 | 79.01 | 83.03 | 78.29 | 79.53 | 211.80K |
| Sep 25, 2026 | 76.65 | 84.35 | 76.65 | 80.73 | 283.70K |
| Sep 24, 2026 | 83.22 | 83.22 | 72.16 | 75.83 | 374.30K |
| Sep 23, 2026 | 86.66 | 86.66 | 82.96 | 84.56 | 211.90K |
| Sep 22, 2026 | 88.98 | 90.68 | 86.81 | 86.84 | 286.00K |
| Sep 21, 2026 | 89.10 | 90.30 | 85.53 | 88.03 | 290.90K |
| Sep 18, 2026 | 90.48 | 90.70 | 84.64 | 89.16 | 370.00K |
About agilon health
agilon health (AGL) is listed on the NYSE and classified by the SEC under “Services-Misc Health & Allied Services, NEC”. Its business address is in WESTERVILLE, OH. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1831097.
AGL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Silvana Battaglia | Director | Jun 4, 2026 |
| Diana Mckenzie | Director | Jun 4, 2026 |
| Sharad Mansukani | Director | Jun 4, 2026 |
| Karen Mcloughlin | Director | Jun 4, 2026 |
| Timothy Patrick O'Rourke | CEO & President | May 11, 2026 |
| Ronald A Williams | Director | Jun 4, 2026 |
| John William Wulf | Director | Jun 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Timothy Gertsch | Chief Accounting Officer | Aug 18, 2026 |
| Timothy Patrick O'Rourke | CEO & President | May 11, 2026 |
| Jeffrey A. Schwaneke | Chief Financial Officer | Jul 2, 2026 |
| Benjamin Shaker | Chief Markets Officer | Apr 16, 2026 |
| Girish Venkatachaliah | Chief Technology Officer | Apr 16, 2026 |
| Denise Zamore | Chief Legal Officer | Aug 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 9, 2026 | Girish Venkatachaliah | Buy | 18,448 | — |
| Mar 9, 2026 | Denise Zamore | Buy | 5,535 | — |
| Mar 9, 2026 | Benjamin Shaker | Buy | 18,448 | — |
| Mar 2, 2026 | Benjamin Shaker | Buy | 500,000 | $0.60 |
| Nov 12, 2025 | John William Wulf | Buy | 81,000 | $0.63 |
AGL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $5.93B | $-391.35M | — | $-105.76M |
| Dec 31, 2024 | $6.06B | $-260.15M | — | $-57.78M |
| Dec 31, 2023 | $4.32B | $-262.60M | — | $-156.20M |
| Dec 31, 2022 | $2.39B | $-106.55M | — | $-130.81M |
| Dec 31, 2021 | $1.52B | $-406.49M | — | $-148.16M |
Latest balance sheet: total assets $1.59B, total liabilities $1.36B, cash $107.18M (as of Jun 30, 2026).
AGL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $107.85 |
| May 6, 2026 | 8-K Item 2.02 (results) | $27.85 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $12.50 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $18.10 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $45.38 |
| May 6, 2025 | 8-K Item 2.02 (results) | $111.50 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $90.75 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $69.75 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Jan 5, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Misc Health & Allied Services, NEC
Davita (DVA)Sotera Health (SHC)Fresenius Medical Care AG (FMS)Progyny (PGNY)Viemed Healthcare (VMD)NewGenIvf (NIVF)Park Dental Partners (PARK)Mangoceuticals (MGRX)Cryo Cell International (CCEL)BioRestorative Therapies (BRTX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on AGL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.